Yuyan Jin, Ph.D.
Affiliations: | 2010 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Pharmacy, Public Health, PharmacologyGoogle:
"Yuyan Jin"Parents
Sign in to add mentor| Robert Bies | grad student | 2010 | University of Pittsburgh | |
| (Quantifying Variability in drug disposition, response and public health outcomes: The implementation of pharmacometric based modeling and simulation approaches.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jin Y, Bies R, Gastonguay MR, et al. (2014) Predicted impact of various clinical practice strategies on cardiovascular risk for the treatment of hypertension: a clinical trial simulation study. Journal of Pharmacokinetics and Pharmacodynamics. 41: 693-704 |
| Maitland ML, Wu K, Sharma MR, et al. (2012) Estimation of renal cell carcinoma treatment effects from disease progression modeling. Clinical Pharmacology and Therapeutics. 93: 345-51 |
| Wessels AM, Jin Y, Pollock BG, et al. (2012) Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study. International Clinical Psychopharmacology. 27: 291-7 |
| Jin Y, Bies R, Gastonguay MR, et al. (2012) Misclassification and discordance of measured blood pressure from patient's true blood pressure in current clinical practice: a clinical trial simulation case study. Journal of Pharmacokinetics and Pharmacodynamics. 39: 283-94 |
| Sharma MR, Karrison TG, Jin Y, et al. (2012) Resampling phase III data to assess phase II trial designs and endpoints. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2309-15 |
| Jin Y, Pollock BG, Coley K, et al. (2010) Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking. Journal of Clinical Pharmacology. 50: 73-80 |
| Jin Y, Pollock BG, Frank E, et al. (2010) Effect of age, weight, and CYP2C19 genotype on escitalopram exposure. Journal of Clinical Pharmacology. 50: 62-72 |
| Jin Y, Pollock BG, Frank E, et al. (2009) The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram. Journal of Clinical Pharmacology. 49: 176-84 |